164 related articles for article (PubMed ID: 37435712)
1. Development of cationic peptide-based hydrogels loaded with iopamidol for CEST-MRI detection.
Di Gregorio E; Rosa E; Ferrauto G; Diaferia C; Gallo E; Accardo A; Terreno E
J Mater Chem B; 2023 Aug; 11(31):7435-7441. PubMed ID: 37435712
[TBL] [Abstract][Full Text] [Related]
2. MRI-CEST assessment of tumour perfusion using X-ray iodinated agents: comparison with a conventional Gd-based agent.
Anemone A; Consolino L; Longo DL
Eur Radiol; 2017 May; 27(5):2170-2179. PubMed ID: 27572810
[TBL] [Abstract][Full Text] [Related]
3. A comparison of iopromide and iopamidol, two acidoCEST MRI contrast media that measure tumor extracellular pH.
Moon BF; Jones KM; Chen LQ; Liu P; Randtke EA; Howison CM; Pagel MD
Contrast Media Mol Imaging; 2015; 10(6):446-55. PubMed ID: 26108564
[TBL] [Abstract][Full Text] [Related]
4. Quantification of iopamidol multi-site chemical exchange properties for ratiometric chemical exchange saturation transfer (CEST) imaging of pH.
Sun PZ; Longo DL; Hu W; Xiao G; Wu R
Phys Med Biol; 2014 Aug; 59(16):4493-504. PubMed ID: 25054859
[TBL] [Abstract][Full Text] [Related]
5. Intraperitoneal Delivery of Iopamidol to Assess Extracellular pH of Orthotopic Pancreatic Tumor Model by CEST-MRI.
Jardim-Perassi BV; Irrera P; Lau JYC; Budzevich M; Whelan CJ; Abrahams D; Ruiz E; Ibrahim-Hashim A; Damgaci Erturk S; Longo DL; Pilon-Thomas SA; Gillies RJ
Contrast Media Mol Imaging; 2023; 2023():1944970. PubMed ID: 36704211
[TBL] [Abstract][Full Text] [Related]
6. A generalized ratiometric chemical exchange saturation transfer (CEST) MRI approach for mapping renal pH using iopamidol.
Wu Y; Zhou IY; Igarashi T; Longo DL; Aime S; Sun PZ
Magn Reson Med; 2018 Mar; 79(3):1553-1558. PubMed ID: 28686805
[TBL] [Abstract][Full Text] [Related]
7. Pilot study of Iopamidol-based quantitative pH imaging on a clinical 3T MR scanner.
Müller-Lutz A; Khalil N; Schmitt B; Jellus V; Pentang G; Oeltzschner G; Antoch G; Lanzman RS; Wittsack HJ
MAGMA; 2014 Dec; 27(6):477-85. PubMed ID: 24570337
[TBL] [Abstract][Full Text] [Related]
8. Imaging Self-Healing Hydrogels and Chemotherapeutics Using CEST MRI at 3 T.
Han X; Lai JHC; Huang J; Park SW; Liu Y; Chan KWY
ACS Appl Bio Mater; 2021 Jul; 4(7):5605-5616. PubMed ID: 35006724
[TBL] [Abstract][Full Text] [Related]
9. A general MRI-CEST ratiometric approach for pH imaging: demonstration of in vivo pH mapping with iobitridol.
Longo DL; Sun PZ; Consolino L; Michelotti FC; Uggeri F; Aime S
J Am Chem Soc; 2014 Oct; 136(41):14333-6. PubMed ID: 25238643
[TBL] [Abstract][Full Text] [Related]
10. Development of a Nanoscale Chemical Exchange Saturation Transfer Magnetic Resonance Imaging Contrast Agent That Measures pH.
Kombala CJ; Kotrotsou A; Schuler FW; de la Cerda J; Ma JC; Zhang S; Pagel MD
ACS Nano; 2021 Dec; 15(12):20678-20688. PubMed ID: 34870957
[TBL] [Abstract][Full Text] [Related]
11. Tumor pH Imaging Using Chemical Exchange Saturation Transfer (CEST)-MRI.
Longo DL; Pirotta E; Gambino R; Romdhane F; Carella A; Corrado A
Methods Mol Biol; 2023; 2614():287-311. PubMed ID: 36587132
[TBL] [Abstract][Full Text] [Related]
12. A machine learning approach that measures pH using acidoCEST MRI of iopamidol.
Li T; Cárdenas-Rodríguez J; Trakru PN; Pagel MD
NMR Biomed; 2023 Oct; 36(10):e4986. PubMed ID: 37280721
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a similarity anisotropic diffusion denoising approach for improving in vivo CEST-MRI tumor pH imaging.
Romdhane F; Villano D; Irrera P; Consolino L; Longo DL
Magn Reson Med; 2021 Jun; 85(6):3479-3496. PubMed ID: 33496986
[TBL] [Abstract][Full Text] [Related]
14. Iopamidol: Exploring the potential use of a well-established x-ray contrast agent for MRI.
Aime S; Calabi L; Biondi L; De Miranda M; Ghelli S; Paleari L; Rebaudengo C; Terreno E
Magn Reson Med; 2005 Apr; 53(4):830-4. PubMed ID: 15799043
[TBL] [Abstract][Full Text] [Related]
15. One-Component Supramolecular Filament Hydrogels as Theranostic Label-Free Magnetic Resonance Imaging Agents.
Lock LL; Li Y; Mao X; Chen H; Staedtke V; Bai R; Ma W; Lin R; Li Y; Liu G; Cui H
ACS Nano; 2017 Jan; 11(1):797-805. PubMed ID: 28075559
[TBL] [Abstract][Full Text] [Related]
16. CEST MRI detectable liposomal hydrogels for multiparametric monitoring in the brain at 3T.
Han X; Huang J; To AKW; Lai JHC; Xiao P; Wu EX; Xu J; Chan KWY
Theranostics; 2020; 10(5):2215-2228. PubMed ID: 32089739
[TBL] [Abstract][Full Text] [Related]
17. Monitor Tumor pHe and Response Longitudinally during Treatment Using CEST MRI-Detectable Alginate Microbeads.
Xiao P; Huang J; Han X; Cheu JWS; Liu Y; Law LH; Lai JHC; Li J; Park SW; Wong CCL; Lam RHW; Chan KWY
ACS Appl Mater Interfaces; 2022 Dec; 14(49):54401-54410. PubMed ID: 36448714
[TBL] [Abstract][Full Text] [Related]
18. In Vitro and In Vivo Assessment of Nonionic Iodinated Radiographic Molecules as Chemical Exchange Saturation Transfer Magnetic Resonance Imaging Tumor Perfusion Agents.
Longo DL; Michelotti F; Consolino L; Bardini P; Digilio G; Xiao G; Sun PZ; Aime S
Invest Radiol; 2016 Mar; 51(3):155-62. PubMed ID: 26460826
[TBL] [Abstract][Full Text] [Related]
19. Dual assessment of kidney perfusion and pH by exploiting a dynamic CEST-MRI approach in an acute kidney ischemia-reperfusion injury murine model.
Irrera P; Consolino L; Cutrin JC; Zöllner FG; Longo DL
NMR Biomed; 2020 Jun; 33(6):e4287. PubMed ID: 32153058
[TBL] [Abstract][Full Text] [Related]
20. A fast multislice sequence for 3D MRI-CEST pH imaging.
Villano D; Romdhane F; Irrera P; Consolino L; Anemone A; Zaiss M; Dastrù W; Longo DL
Magn Reson Med; 2021 Mar; 85(3):1335-1349. PubMed ID: 33031591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
